Tag:Chill Brands

European Cannabis Stocks Review: Intercure Sues Better To Recover Loans As Acquisition Falls Through, Yooma Pulls Out Of Japan & More From Chill Brands

Intercure  Israel’s largest cannabis company, Intercure, saw its stock fall around 10% this week as it became involved in a legal dispute with Cann Pharmaceuticals,...

European Cannabis Stocks Review: DeepVerge Drops 60% As It Warns May Not Have ‘Sufficient Equity’ To Make Loan Repayments

WHILE last week’s news from the US saw many EU cannabis stocks experience a spike in stock price on Friday, these gains were almost...

Grow Group, Kanabo, MGC Pharma & Celadon Pharma All Report Growing Revenues, But Continue To Post Losses

AMID the economic chaos that dominated the headlines over the past week, nearly half-a-dozen UK-based or UK-listed cannabis companies released their latest financial figures.  Grow...

European Cannabis Stocks Review: £22m Wiped From LSE-Listed Cannabis Stocks Amid Market Chaos

FOLLOWING a few weeks of relative positivity for many of the stocks listed on the London Stock Exchange (LSE), the market chaos caused by...

European Cannabis Stocks Review: Chill Brands Becomes Latest UK-Listed Stock To Stage Comeback, IM Cannabis Edges Closer To Delisting, & More From Cellular Goods

THIS week has seen European cannabis stocks once again gain momentum in the face of dismal economic news. In the UK this week, news...

European Cannabis Stocks Review: Akanda’s ‘Concerned Shareholders’ Oust All Directors Except CEO To Prevent ‘Potentially Irreparable Harm’ – More From Goodbody Health & Chill...

It has been another week of positive developments for the cannabis industry across Europe, with yet more markets making progress on cannabis liberalisation. Germany's...

Chill Brands Targets Near £4m Capital Raise To Fund Fresh Strategy & £1.3m Chill.com Domain

CHILL Brands’ shareholders have voted in favour of plans for a new £3.5m fundraise alongside a separate £484,000 open share offer to ‘ensure the...

EU Cannabis Stocks Review: How Ukraine Crisis Is Impacting Cannabis Stocks, Chill Brands’ Revenue Could Be $1m Less & More From Tilray and MGC...

LAST week began with a number of European cannabis stocks levelling out following dramatic declines days earlier in reaction to Russia’s invasion of Ukraine.  While...

Latest news

European Cannabis Stocks Review: Celadon Shares Spike 150% On Licence Update, OCT Continues Recovery, & Creso Pharma Censured By ASX

Celadon Pharmaceuticals  Celadon Pharmaceuticals stock has skyrocketed by more than 150% this week following the announcement that its current Home...
- Advertisement -spot_imgspot_img

Benefits of F1 Cannabis Hybrids from Royal Queen Seeds

F1 hybrids have revolutionised the way we grow and use plants. Now, F1 cannabis seeds are bringing growers, smokers,...

Celadon Pharmaceuticals Announces Home Office Approval Of Licence For Commercial Sale Of GMP Cannabis

PRESS RELEASE FURTHER to the announcement dated 16 January 2023, Celadon Pharmaceuticals Plc (AIM: CEL), a UK-based pharmaceutical company focused on...

Must read